CA2847938C - Titanium based ceramic reinforced alloy for use in medical implants - Google Patents
Titanium based ceramic reinforced alloy for use in medical implants Download PDFInfo
- Publication number
- CA2847938C CA2847938C CA2847938A CA2847938A CA2847938C CA 2847938 C CA2847938 C CA 2847938C CA 2847938 A CA2847938 A CA 2847938A CA 2847938 A CA2847938 A CA 2847938A CA 2847938 C CA2847938 C CA 2847938C
- Authority
- CA
- Canada
- Prior art keywords
- ingot
- vol
- alloy
- titanium
- phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229910045601 alloy Inorganic materials 0.000 title claims abstract description 65
- 239000000956 alloy Substances 0.000 title claims abstract description 65
- 239000010936 titanium Substances 0.000 title claims abstract description 27
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 title claims abstract description 26
- 229910052719 titanium Inorganic materials 0.000 title claims abstract description 25
- 239000007943 implant Substances 0.000 title claims abstract description 20
- 239000000919 ceramic Substances 0.000 title claims abstract description 10
- 239000013078 crystal Substances 0.000 claims abstract description 23
- 239000010703 silicon Substances 0.000 claims abstract description 20
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229910052710 silicon Inorganic materials 0.000 claims abstract description 19
- 239000010955 niobium Substances 0.000 claims abstract description 18
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229910052758 niobium Inorganic materials 0.000 claims abstract description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 7
- 229910052757 nitrogen Inorganic materials 0.000 claims description 7
- 239000001301 oxygen Substances 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- 238000000137 annealing Methods 0.000 claims description 4
- 238000005266 casting Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 150000002739 metals Chemical class 0.000 claims description 3
- 239000006104 solid solution Substances 0.000 claims description 3
- 229910001069 Ti alloy Inorganic materials 0.000 abstract description 11
- 229910001257 Nb alloy Inorganic materials 0.000 abstract description 4
- 229910000676 Si alloy Inorganic materials 0.000 abstract description 2
- 210000000988 bone and bone Anatomy 0.000 description 8
- 239000000463 material Substances 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000000399 orthopedic effect Effects 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 238000007743 anodising Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005498 polishing Methods 0.000 description 3
- 229910052720 vanadium Inorganic materials 0.000 description 3
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 239000010952 cobalt-chrome Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000000365 skull melting Methods 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000004053 dental implant Substances 0.000 description 1
- 210000003027 ear inner Anatomy 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229910052735 hafnium Inorganic materials 0.000 description 1
- VBJZVLUMGGDVMO-UHFFFAOYSA-N hafnium atom Chemical compound [Hf] VBJZVLUMGGDVMO-UHFFFAOYSA-N 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- RJSRQTFBFAJJIL-UHFFFAOYSA-N niobium titanium Chemical compound [Ti].[Nb] RJSRQTFBFAJJIL-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C14/00—Alloys based on titanium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22D—CASTING OF METALS; CASTING OF OTHER SUBSTANCES BY THE SAME PROCESSES OR DEVICES
- B22D7/00—Casting ingots, e.g. from ferrous metals
- B22D7/005—Casting ingots, e.g. from ferrous metals from non-ferrous metals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mechanical Engineering (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Metallurgy (AREA)
- Inorganic Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
A titanium based, ceramic reinforced alloy ingot for use in producing medical implants. An ingot is formed from an alloy having comprising from about 5 to about 35 wt. % niobium, from about 0.5 to about 3.5 wt. % silicon, and from about 61.5 to about 94.5 wt. % of titanium. The alloy has a hexagonal crystal lattice a phase of from about 20 vol % to about 70 vol %, and a cubic body centered p crystal lattice phase of from about 30 vol. % to about 80 vol. %. The ingot has an ultimate tensile strength of about 940 MPa or more, and a Young's modulus of about 150 GPa or less. A molten substantially uniform admixture of a niobium, silicon, and titanium alloy is formed, cast into a shape, and cooled into an ingot. The ingot may then be formed into a medical implant and optionally annealed.
Description
Docket No: PLS-102 TITANIUM BASED CERAMIC REINFORCED ALLOY
FOR USE IN MEDICAL IMPLANTS
BACKGROUND OF THE INVENTION
Field of the Invention The invention relates to a titanium based, ceramic reinforced alloy ingot for use in producing medical implants. More particularly, the invention pertains to a ceramic reinforced alloy ingot comprising titanium, niobium and silicon. The alloy has both an a crystal phase and a 3 crystal phase. The ingot has an ultimate tensile strength of about 940 MPa or more, and a Young's modulus of about 150 GPa or less.
Description of the Related Art There is great commercial interest in the production of biocompatible, medically suitable implants for surgically jointing bone and implanting teeth. Medical implants such as screws, pins, rods, bars, springs, coils, cables, staples, clips, plates and the like require materials with very high tensile strength and high cyclic fatigue life while also having a modulus of elasticity low enough to be compatible with bone. Common alloys include titanium, stainless steel and cobalt chrome alloys. Stainless steel and cobalt chrome alloys exhibit very high tensile strength, but both contain nickel and chromium which are known irritants to the body. In addition, these alloys have low ductility and a Young's modulus approaching five times that of bone. This high tensile strength and Young's modulus also makes it difficult to machine these components cost effectively using conventional techniques. Titanium and its alloys are especially popular choices for orthopedic bone screws and plates commonly used for spinal fixation.
Titanium alloys for a variety of applications are known in the art and there are numerous literature references disclosing a wide range of elements which are used to provide alloys having desired characteristics, such as increased tensile strength and ductility. Generally, titanium and its alloys may exist in one or a mixture of two basic crystalline structures, namely the a phase, which is a hexagonal close-packed structure, and the 13 phase which is a body-centered cubic structure.
The commercially pure grades of titanium alloys have low tensile strengths but show no signs of tissue irritation. These alloys are commonly used for orthopedic plates which are implanted externally to the bone structure and can therefore have a larger size. Ti6A1V4 alloys are commonly used for higher strength applications such as fixation screws or plates which must be contained in a small area. One known medically implantable alloy is disclosed in U.S. patent 6,752,882. It provides a biocompatible low modulus, high strength titanium-niobium alloy containing a phase as a major phase and consisting essentially of 10-30 wt %
of Nb and the balance titanium. U.S. patent 5,954,724 relates to titanium alloys suitable for use for medical implants and devices having a high-strength, low-modulus, and high hardness with improved corrosion resistance due to the addition of hafnium and molybdenum, and which additionally allow for surface hardening of an implant made of this alloy. U.S. patent 7,892,369 provides a method for modifying the microstructure of titanium alloys for use in the manufacture of orthopedic prostheses. An orthopedic prosthesis is initially formed from a titanium alloy and subsequently subjected to a thermal treatment followed by rapid quenching. The microstructure of the titanium alloy in the prosthesis has improved resistance to fretting fatigue. U.S. patent 7,682,473 provides an implant prosthesis composed of a TiAlNb alloy having a modulus near that for bone to
FOR USE IN MEDICAL IMPLANTS
BACKGROUND OF THE INVENTION
Field of the Invention The invention relates to a titanium based, ceramic reinforced alloy ingot for use in producing medical implants. More particularly, the invention pertains to a ceramic reinforced alloy ingot comprising titanium, niobium and silicon. The alloy has both an a crystal phase and a 3 crystal phase. The ingot has an ultimate tensile strength of about 940 MPa or more, and a Young's modulus of about 150 GPa or less.
Description of the Related Art There is great commercial interest in the production of biocompatible, medically suitable implants for surgically jointing bone and implanting teeth. Medical implants such as screws, pins, rods, bars, springs, coils, cables, staples, clips, plates and the like require materials with very high tensile strength and high cyclic fatigue life while also having a modulus of elasticity low enough to be compatible with bone. Common alloys include titanium, stainless steel and cobalt chrome alloys. Stainless steel and cobalt chrome alloys exhibit very high tensile strength, but both contain nickel and chromium which are known irritants to the body. In addition, these alloys have low ductility and a Young's modulus approaching five times that of bone. This high tensile strength and Young's modulus also makes it difficult to machine these components cost effectively using conventional techniques. Titanium and its alloys are especially popular choices for orthopedic bone screws and plates commonly used for spinal fixation.
Titanium alloys for a variety of applications are known in the art and there are numerous literature references disclosing a wide range of elements which are used to provide alloys having desired characteristics, such as increased tensile strength and ductility. Generally, titanium and its alloys may exist in one or a mixture of two basic crystalline structures, namely the a phase, which is a hexagonal close-packed structure, and the 13 phase which is a body-centered cubic structure.
The commercially pure grades of titanium alloys have low tensile strengths but show no signs of tissue irritation. These alloys are commonly used for orthopedic plates which are implanted externally to the bone structure and can therefore have a larger size. Ti6A1V4 alloys are commonly used for higher strength applications such as fixation screws or plates which must be contained in a small area. One known medically implantable alloy is disclosed in U.S. patent 6,752,882. It provides a biocompatible low modulus, high strength titanium-niobium alloy containing a phase as a major phase and consisting essentially of 10-30 wt %
of Nb and the balance titanium. U.S. patent 5,954,724 relates to titanium alloys suitable for use for medical implants and devices having a high-strength, low-modulus, and high hardness with improved corrosion resistance due to the addition of hafnium and molybdenum, and which additionally allow for surface hardening of an implant made of this alloy. U.S. patent 7,892,369 provides a method for modifying the microstructure of titanium alloys for use in the manufacture of orthopedic prostheses. An orthopedic prosthesis is initially formed from a titanium alloy and subsequently subjected to a thermal treatment followed by rapid quenching. The microstructure of the titanium alloy in the prosthesis has improved resistance to fretting fatigue. U.S. patent 7,682,473 provides an implant prosthesis composed of a TiAlNb alloy having a modulus near that for bone to
2 prevent stress shielding, and a tensile and compressive strength and fracture toughness equal to or greater than that of bone. A key problem with other alloys which use aluminum and vanadium is the suspected effect of Al and V when movement and fretting are involved. The release of Al and V into the blood stream could cause irritation for the patient in the long term. Another issue with certain grades of titanium is the so called "notch effect" during cyclic fatigue.
Prepared and polished samples of certain titanium alloys have been shown to have fatigue strength near the ultimate tensile strength. However, when a notch is introduced to the sample, the fatigue strength can be lowered to 40% of the ultimate tensile strength. Since implantable devices must be laser marked with the appropriate tracking information, a notch situation always exists and care must be taken not to exceed the notch fatigue strength.
The problems associated with designing an implantable device are specifically, providing an alloy with high tensile strength, and a marginal Young's modulus that contains no known irritants which can be economically machined with conventional methods. The present invention addresses all these issues. The invention provides an alloy of titanium, niobium and silicon. Titanium and niobium alloys are known to form alloys with very low Young's modulus (50-80GPa). A problem with these known alloys is that they do not have sufficient strength for the manufacture of orthopedic devices such as bone plates and fixation screws. This invention overcomes the limitations of conventional alloys by including within a solid solution of the metals, a glassy silicon ceramic which acts to absorb energy during crack propagation and retard dislocations during applied stress. The atomic percent of this glassy silicon ceramic is controlled as to still allow for a moderately low Young's modulus and good formability. The inventive alloy of primarily Ti with the addition of Nb and Si produces alloys which have a complex alpha/beta structure with an amount of glassy material.
The
Prepared and polished samples of certain titanium alloys have been shown to have fatigue strength near the ultimate tensile strength. However, when a notch is introduced to the sample, the fatigue strength can be lowered to 40% of the ultimate tensile strength. Since implantable devices must be laser marked with the appropriate tracking information, a notch situation always exists and care must be taken not to exceed the notch fatigue strength.
The problems associated with designing an implantable device are specifically, providing an alloy with high tensile strength, and a marginal Young's modulus that contains no known irritants which can be economically machined with conventional methods. The present invention addresses all these issues. The invention provides an alloy of titanium, niobium and silicon. Titanium and niobium alloys are known to form alloys with very low Young's modulus (50-80GPa). A problem with these known alloys is that they do not have sufficient strength for the manufacture of orthopedic devices such as bone plates and fixation screws. This invention overcomes the limitations of conventional alloys by including within a solid solution of the metals, a glassy silicon ceramic which acts to absorb energy during crack propagation and retard dislocations during applied stress. The atomic percent of this glassy silicon ceramic is controlled as to still allow for a moderately low Young's modulus and good formability. The inventive alloy of primarily Ti with the addition of Nb and Si produces alloys which have a complex alpha/beta structure with an amount of glassy material.
The
3 resulting alloy has a higher strength then the titanium grades presently used in medical implants while retaining a comparable elastic modulus.
SUMMARY OF THE INVENTION
The invention provides an ingot comprising an alloy, the alloy comprising from about 5 wt. % to about 35 wt. % of niobium, from about 0.5 wt. % to about 3.5 wt. % of silicon, and from about 61.5 wt. % to about 94.5 wt. % of titanium, the alloy having a hexagonal crystal lattice a phase of from about 20 vol % to about 70 vol %, and a cubic body centered 13 crystal lattice phase of from about 30 vol.
% to about 80 vol. %, the ingot having an ultimate tensile strength of about MPa or more, and a Young's modulus of about 150 GPa or less.
The invention also provides a method of forming an ingot which comprises forming a molten alloy comprising a substantially uniform admixture of from about 5 wt. % to about 35 wt. % of niobium, from about 0.5 wt. % to about 3.5 wt. % of silicon, and from about 61.5 wt. % to about 94.5 wt. % of titanium, casting the molten alloy into a shape, and then cooling the shape into an ingot, the alloy having a hexagonal crystal lattice a phase of from about 20 vol % to about 70 vol %, and a cubic body centered 13 crystal lattice phase of from about 30 vol.
% to about 80 vol. %, the ingot having an ultimate tensile strength of about MPa or more, and a Young's modulus of about 150 GPa or less.
SUMMARY OF THE INVENTION
The invention provides an ingot comprising an alloy, the alloy comprising from about 5 wt. % to about 35 wt. % of niobium, from about 0.5 wt. % to about 3.5 wt. % of silicon, and from about 61.5 wt. % to about 94.5 wt. % of titanium, the alloy having a hexagonal crystal lattice a phase of from about 20 vol % to about 70 vol %, and a cubic body centered 13 crystal lattice phase of from about 30 vol.
% to about 80 vol. %, the ingot having an ultimate tensile strength of about MPa or more, and a Young's modulus of about 150 GPa or less.
The invention also provides a method of forming an ingot which comprises forming a molten alloy comprising a substantially uniform admixture of from about 5 wt. % to about 35 wt. % of niobium, from about 0.5 wt. % to about 3.5 wt. % of silicon, and from about 61.5 wt. % to about 94.5 wt. % of titanium, casting the molten alloy into a shape, and then cooling the shape into an ingot, the alloy having a hexagonal crystal lattice a phase of from about 20 vol % to about 70 vol %, and a cubic body centered 13 crystal lattice phase of from about 30 vol.
% to about 80 vol. %, the ingot having an ultimate tensile strength of about MPa or more, and a Young's modulus of about 150 GPa or less.
4 DESCRIPTION OF THE INVENTION
An alloy is formed by combining commercially pure quantities of titanium, niobium and silicon. These may be obtained in the form of bars, wires, powders, particles, or any other convenient form. These are then heated until each is molten and blended into a substantially uniform admixture. The amount of titanium may range from about 61.5 wt. % to about 94.5 wt. %, preferably from about 72.5 wt. % to about 92 wt. %, and more preferably from about 78 wt. % to about 88.75 wt. %.
The amount of niobium may range from about 5 wt. % to about 35 wt. %, preferably from about 7 wt. % to about 25 wt. %, and more preferably from about 10 wt. % to about 20 wt. %. The amount of silicon may range from about 0.5 wt.
% to about 3.5 wt. %, preferably from about 1 wt. % to about 2.5 wt. %, and more from about 1.25 wt. % to about 2 wt. %. Preferably the alloy has no more than wt. % of nitrogen, oxygen, or carbon. More preferably the alloy has about 1 wt.
% or less of nitrogen, oxygen or carbon. Still more preferably the alloy has about 0.5 wt. % or less of nitrogen, oxygen or carbon. In a most preferred embodiment, the alloy comprises only these three elements such that the alloy has from about 5 wt. % to about 35 wt. % of niobium, from about 0.5 wt. % to about 3.5 wt. % of silicon, and the balance being titanium, apart from incidental impurities.
A method for preparing such a high strength, low modulus, biocompatible titanium alloy involves mechanically blending the above components, and then heating them until melted, one or more times.
The alloys are preferably made by mechanically blending accurately weighed portions of the pure elements and melting the blend in a furnace such as a plasma arc furnace or vacuum arc furnace, and remelting as necessary to achieve uniformity, and then casting and cooling. One example of a method of melting includes combining the components in a commercially available arc-melting
An alloy is formed by combining commercially pure quantities of titanium, niobium and silicon. These may be obtained in the form of bars, wires, powders, particles, or any other convenient form. These are then heated until each is molten and blended into a substantially uniform admixture. The amount of titanium may range from about 61.5 wt. % to about 94.5 wt. %, preferably from about 72.5 wt. % to about 92 wt. %, and more preferably from about 78 wt. % to about 88.75 wt. %.
The amount of niobium may range from about 5 wt. % to about 35 wt. %, preferably from about 7 wt. % to about 25 wt. %, and more preferably from about 10 wt. % to about 20 wt. %. The amount of silicon may range from about 0.5 wt.
% to about 3.5 wt. %, preferably from about 1 wt. % to about 2.5 wt. %, and more from about 1.25 wt. % to about 2 wt. %. Preferably the alloy has no more than wt. % of nitrogen, oxygen, or carbon. More preferably the alloy has about 1 wt.
% or less of nitrogen, oxygen or carbon. Still more preferably the alloy has about 0.5 wt. % or less of nitrogen, oxygen or carbon. In a most preferred embodiment, the alloy comprises only these three elements such that the alloy has from about 5 wt. % to about 35 wt. % of niobium, from about 0.5 wt. % to about 3.5 wt. % of silicon, and the balance being titanium, apart from incidental impurities.
A method for preparing such a high strength, low modulus, biocompatible titanium alloy involves mechanically blending the above components, and then heating them until melted, one or more times.
The alloys are preferably made by mechanically blending accurately weighed portions of the pure elements and melting the blend in a furnace such as a plasma arc furnace or vacuum arc furnace, and remelting as necessary to achieve uniformity, and then casting and cooling. One example of a method of melting includes combining the components in a commercially available arc-melting
5 vacuum pressure casting system. A melting chamber is first evacuated and purged with an inert gas such as argon. An argon pressure of, for example 1.5 kgf/cm2 may be maintained during melting. The appropriate amounts of titanium, niobium and silicon are prepared by electron beam skull melting with induction stirring of the melt. The resulting mixture may optionally be re-melted multiple times to improve homogeneity. The molten alloy is then cast, or drawn out of the crucible by a water cooled rod to form a cylindrical ingot, with cooling. The alloy has a combination crystal lattice structure of both a and 13 phases. In particular, the alloy has a hexagonal crystal lattice a phase of from about 20 vol % to about 70 vol %, and a cubic body centered 13 crystal lattice phase of from about 30 vol. % to about 80 vol. %. Preferably the alloy has a hexagonal crystal lattice a phase of from about 40 vol. % to about 70 vol. %, and a cubic body centered i3 crystal lattice phase of from about 30 vol. % to about 60 vol. %. More preferably the alloy comprises a hexagonal crystal lattice a phase of from about 45 vol.
% to about 65 vol. %, and a cubic body centered 13 crystal lattice phase of from about 45 vol. % to about 60 vol. %.
The resulting ingot has an ultimate tensile strength of about 940 MPa or more, usually from about 1000 MPa to about 1400 MPa, and more usually from about 1100 MPa to about 1300 MPa. The resulting ingot has a Young's modulus of about 150 GPa or less, usually from about 100 GPa to about 150 GPa, and more usually from about 110 GPa to about 140 GPa.
The resulting ingot may then be formed into the desired medial implant shape, such as those in the form of a screw, pin, rod, bar, spring, coil, cable, staple, clip, plate, or the like. The implant may also be form into customized shapes such as those conforming to hip joint stems, femoral heads, knee femoral components,
% to about 65 vol. %, and a cubic body centered 13 crystal lattice phase of from about 45 vol. % to about 60 vol. %.
The resulting ingot has an ultimate tensile strength of about 940 MPa or more, usually from about 1000 MPa to about 1400 MPa, and more usually from about 1100 MPa to about 1300 MPa. The resulting ingot has a Young's modulus of about 150 GPa or less, usually from about 100 GPa to about 150 GPa, and more usually from about 110 GPa to about 140 GPa.
The resulting ingot may then be formed into the desired medial implant shape, such as those in the form of a screw, pin, rod, bar, spring, coil, cable, staple, clip, plate, or the like. The implant may also be form into customized shapes such as those conforming to hip joint stems, femoral heads, knee femoral components,
6 . , knee tibial components, intramedullary nails, inner ear vent tubes, spinal plates, spinal disks, pelvic plates, dental implants, cardiovascular implants, compression hip screws, and the like. Such forming may be done by the use of customary machine tooling. Optionally either the cast ingot or the machined medical implant may be annealed for additional strength, polished or anodized by well known methods. Annealing may be done by heating at temperatures ranging from about 500 C. to about 1200 C., preferably from about 750 C. to about 1000 C., for from about 20 minutes to about 360 minutes, preferably from about 40 minutes to about 120 minutes. Polishing may be done by mechanical burnishing.
Anodizing may be done by electrochemically oxidizing the surface.
The following non-limiting examples serve to illustrate the invention.
EXAMPLES
Three alloys were formed and tested in both the as cast condition, and after annealing at 950 C for 1 hour in vacuum. The alloys were prepared by electron beam skull melting with induction stirring of the melt. The resulting material was drawing out of the crucible by a water cooled rod to form a cylindrical ingot.
Anodizing may be done by electrochemically oxidizing the surface.
The following non-limiting examples serve to illustrate the invention.
EXAMPLES
Three alloys were formed and tested in both the as cast condition, and after annealing at 950 C for 1 hour in vacuum. The alloys were prepared by electron beam skull melting with induction stirring of the melt. The resulting material was drawing out of the crucible by a water cooled rod to form a cylindrical ingot.
7 , Young's Yield Alloy UTS Modulus Strength Elongation Test Condition Nb Si (Mpa) (GPa) (Mpa) (%) 1 As Cast 10 1.1 1012 113 940 4.6 2 As Cast 13 1.5 995 112 937 6.2 3 As Cast 21 1.25 1022 110 960 4.8 la Annealed 10 1.1 1006 81 945 4.5 2a Annealed 13 1.5 1008 83 957 3.3 3a Annealed 21 1.25 957 76 850 3.25 The sample ingots were subjected to machinability tests, polishing tests and color anodizing. The composition performed excellently in all cases, with the polishing and anodizing exceeding the characteristics of commercially available Grade 4 and Grade 23 titanium. Detailed chemical and phase analysis of the Ti-21Nb-1.25Si material was performed. The phase analysis shows a roughly 55/45 alpha/beta structure. XPS analysis confirmed that there existed a large number of atoms in a glassy phase with 1.6at % of the material existing as SiC.
This SiC glassy ceramic is deposited at the grain boundaries. Given the high fracture toughness of the carbide these interstitial components act not only prohibit dislocation movement but also absorb energy in the case of crack propagation. The presence of carbon in the alloy used to form the SiC is present in the starting raw material as a typical impurity.
While the present invention has been particularly shown and described with reference to preferred embodiments, it will be readily appreciated by those of ordinary skill in the art that various changes and modifications may be made without departing from the spirit and scope of the invention. It is intended that the claims be interpreted to cover the disclosed embodiment, those alternatives which have been discussed above and all equivalents thereto.
This SiC glassy ceramic is deposited at the grain boundaries. Given the high fracture toughness of the carbide these interstitial components act not only prohibit dislocation movement but also absorb energy in the case of crack propagation. The presence of carbon in the alloy used to form the SiC is present in the starting raw material as a typical impurity.
While the present invention has been particularly shown and described with reference to preferred embodiments, it will be readily appreciated by those of ordinary skill in the art that various changes and modifications may be made without departing from the spirit and scope of the invention. It is intended that the claims be interpreted to cover the disclosed embodiment, those alternatives which have been discussed above and all equivalents thereto.
8
Claims (18)
1. An ingot comprising an alloy, the alloy consisting essentially of from about 5 wt. %
to about 35 wt. % of niobium, from about 0.5 wt. % to about 3.5 wt. % of silicon, and from about 61.5 wt. % to about 94.5 wt. % of titanium, the alloy having no more than 2 wt. % of nitrogen, no more than 2 wt. % of oxygen, and no more than 2 wt. % of carbon, the alloy having a hexagonal crystal lattice a phase of from about 20 vol. %
to about 70 vol. %, and a cubic body centered p crystal lattice phase of from about 30 vol. % to about 80 vol. %, the ingot having an ultimate tensile strength of about 1,000 MPa or more, and a Young's modulus of 150 GPa or less, and within the solid solution of the .. metals including a glassy silicon ceramic.
to about 35 wt. % of niobium, from about 0.5 wt. % to about 3.5 wt. % of silicon, and from about 61.5 wt. % to about 94.5 wt. % of titanium, the alloy having no more than 2 wt. % of nitrogen, no more than 2 wt. % of oxygen, and no more than 2 wt. % of carbon, the alloy having a hexagonal crystal lattice a phase of from about 20 vol. %
to about 70 vol. %, and a cubic body centered p crystal lattice phase of from about 30 vol. % to about 80 vol. %, the ingot having an ultimate tensile strength of about 1,000 MPa or more, and a Young's modulus of 150 GPa or less, and within the solid solution of the .. metals including a glassy silicon ceramic.
2. The ingot of claim 1, wherein the alloy comprises from about 5 wt. % to about 35 wt.
% of niobium, from about 0.5 wt. % to about 3.5 wt. % of silicon, and the balance titanium.
% of niobium, from about 0.5 wt. % to about 3.5 wt. % of silicon, and the balance titanium.
3. The ingot of claim 1, wherein the alloy comprises from about 7 wt. % to about 25 wt.
.. % of niobium, from about 1 wt. % to about 2.5 wt. % of silicon, and from about 72.5 wt.
% to about 92 wt. % of titanium.
.. % of niobium, from about 1 wt. % to about 2.5 wt. % of silicon, and from about 72.5 wt.
% to about 92 wt. % of titanium.
4. The ingot of claim 1, wherein the alloy comprises from about 10 wt. % to about 20 wt. % of niobium, from about 1.25 wt. % to about 2 wt. % of silicon, and from about 78 wt. % to about 88.75 wt. % of titanium.
.. 5. The ingot of claim 1, which has an ultimate tensile strength of from about 1000 MPa to about 1400 MPa, and a Young's modulus of from about 100 GPa to about 150 GPa.
6. The ingot of claim 1, which has an ultimate tensile strength of from about 1100 MPa to about 1300 MPa, and a Young's modulus of from about 110 GPa to about 140 GPa.
7. The ingot of claim 1, wherein the alloy has 1 wt. % of nitrogen or less, 1 wt. % of oxygen or less, and 1 wt. % of carbon or less.
Date Recue/Date Received 2020-07-14
Date Recue/Date Received 2020-07-14
8. The ingot of claim 1, wherein the alloy has 0.5 wt. % of nitrogen or less, 0.5 wt. % of oxygen or less, and 0.5 wt. % of carbon or less.
9. The ingot of claim 1, wherein the alloy comprises a hexagonal crystal lattice a phase of from about 40 vol. % to about 70 vol. %, and a cubic body centered p crystal lattice phase of from about 30 vol. % to about 60 vol. %.
10. The ingot of claim 1, wherein the alloy comprises a hexagonal crystal lattice a phase of from about 45 vol. % to about 65 vol. %, and a cubic body centered p crystal lattice phase of from about 45 vol. % to about 60 vol. %.
11. A medical implant formed from the ingot of any one of claims 1 to 10.
12. The medical implant of claim 11, which is in the form of a screw, pin, rod, bar, spring, coil, cable, staple, clip or plate.
13. A method of forming an ingot which comprises forming a molten alloy consisting essentially of a substantially uniform admixture of from about 5 wt. % to about 35 wt.
% of niobium, from about 0.5 wt. % to about 3.5 wt. % of silicon, and from about 61.5 wt. % to about 94.5 wt. % of titanium, the alloy having no more than 2 wt. %
of nitrogen, no more than 2 wt. % of oxygen, and no more than 2 wt. % of carbon, casting the molten alloy into a shape, and then cooling the shape into an ingot, the alloy having a hexagonal crystal lattice a phase of from about 20 vol.% to about 70 vol.%, and a cubic body centered p crystal lattice phase of from about 30 vol.% to about 80 vol.%, the ingot having an ultimate tensile strength of about 940 MPa or more, and a Young's modulus of 150 GPa or less, and within the solid solution of the metals including a glassy silicon ceramic.
% of niobium, from about 0.5 wt. % to about 3.5 wt. % of silicon, and from about 61.5 wt. % to about 94.5 wt. % of titanium, the alloy having no more than 2 wt. %
of nitrogen, no more than 2 wt. % of oxygen, and no more than 2 wt. % of carbon, casting the molten alloy into a shape, and then cooling the shape into an ingot, the alloy having a hexagonal crystal lattice a phase of from about 20 vol.% to about 70 vol.%, and a cubic body centered p crystal lattice phase of from about 30 vol.% to about 80 vol.%, the ingot having an ultimate tensile strength of about 940 MPa or more, and a Young's modulus of 150 GPa or less, and within the solid solution of the metals including a glassy silicon ceramic.
14. The method of claim 13 wherein the alloy comprises from about 5 wt.% to about 35 wt.% of niobium, from about 0.5 wt.% to about 3.5 wt.% of silicon, and the balance being titanium.
Date Recue/Date Received 2020-07-14
Date Recue/Date Received 2020-07-14
15. The method of claim 13, further comprising the subsequent step of forming the ingot into a medical implant.
16. The method of claim 15, wherein the medical implant is in the form of a screw, pin, rod, bar, spring, coil, cable, staple, clip or plate.
17. The method of claim 13, further comprising the subsequent step of annealing the ingot.
18. The method of claim 15, further comprising the subsequent step of annealing the medical implant.
Date Recue/Date Received 2020-07-14
Date Recue/Date Received 2020-07-14
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2847938A CA2847938C (en) | 2014-03-31 | 2014-03-31 | Titanium based ceramic reinforced alloy for use in medical implants |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2847938A CA2847938C (en) | 2014-03-31 | 2014-03-31 | Titanium based ceramic reinforced alloy for use in medical implants |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2847938A1 CA2847938A1 (en) | 2015-09-30 |
CA2847938C true CA2847938C (en) | 2021-05-25 |
Family
ID=54250514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2847938A Active CA2847938C (en) | 2014-03-31 | 2014-03-31 | Titanium based ceramic reinforced alloy for use in medical implants |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2847938C (en) |
-
2014
- 2014-03-31 CA CA2847938A patent/CA2847938C/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2847938A1 (en) | 2015-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3330380B2 (en) | Hot implant, method of manufacturing the same, and alloy useful for hot implant | |
EP0359446B1 (en) | High strength, low modulus titanium alloy | |
WO2005064026A1 (en) | Super elasticity and low modulus ti alloy and its manufacture process | |
AU2023201949A1 (en) | Titanium based ceramic reinforced alloy | |
Patricio et al. | Relationship between microstructure, phase transformation, and mechanical behavior in Ti–40Ta alloys for biomedical applications | |
US9039963B2 (en) | Titanium based ceramic reinforced alloy for use in medical implants | |
US20090088845A1 (en) | Titanium tantalum oxygen alloys for implantable medical devices | |
JP6494172B2 (en) | Ceramic reinforced titanium-based alloy for use in medical implants | |
EP2927334B1 (en) | Titanium based ceramic reinforcement alloy for use in medical implants | |
CA2847938C (en) | Titanium based ceramic reinforced alloy for use in medical implants | |
AU2014201877B2 (en) | Titanium based ceramic reinforced alloy for use in medical implants | |
US6726787B2 (en) | Process for making a work piece having a major phase of α from a titanium alloy | |
US20130139933A1 (en) | Method for enhancing mechanical strength of a titanium alloy by aging | |
WO2015030131A1 (en) | Zirconium alloy for organism, method for manufacturing said alloy, and medical tool for organism incorporating zirconium alloy for organism | |
WO2014156934A1 (en) | Biocompatible zirconium alloy and biomedical instrument using same | |
KR101678750B1 (en) | '' method for increasing mechanical strength of titanium alloys having '' phase by cold working | |
Fikeni | Microstructural Evolution and its Influence on Mechanical Properties of Ti-Nb Binary Alloys | |
Chung et al. | Effect of Solution Treatment Time on Structure and Mechanical Properties of Fast‐Cooled Ti–7.5 Mo Alloy | |
Júnior et al. | Effect of heat treatment on microstructure and mechanical properties of Ti30Ta alloy for biomedical applications | |
CN118480719A (en) | Biomedical six-element beta titanium alloy with low elastic modulus and high plasticity | |
CN116334446A (en) | Rare earth element Y doped Ti-Nb based titanium alloy and preparation and processing methods thereof | |
CN118835145A (en) | (Ti-Zr-Nb-Ta) -Ga series high/medium entropy alloy and preparation method and application thereof | |
Турлыбекулы et al. | Preparation of a ternary alloy of the Ti-Nb-Ta system for further use in medicine | |
CN116334445A (en) | Rare earth doped Ti-Nb-Dy alloy and preparation and processing methods thereof | |
Zhang et al. | Effect of Heat Treatment on Microstructure and Mechanical Properties of a Ti-Mo-Zr alloy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20181228 |